Study to Evaluate the Detection Performance and Safety of an Investigational Wearable Cardioverter Defibrillator (WCD)

Overview

Información sobre este estudio

The purpose of this study is to evaluate the detection performance and safety of an investigational Wearable Cardioverter defibrillator (WCD). 

Elegibilidad para la participación

Los requisitos de elegibilidad de los participantes incluyen la edad, el sexo, el tipo y el estadio de la enfermedad, y los problemas de salud o tratamientos previos. Las pautas difieren de un estudio a otro e identifican quiénes pueden o no pueden participar. No hay garantía de que cada persona elegible que desee participar en un ensayo se inscribirá. Comunícate con el equipo del estudio para analizar la elegibilidad del estudio y la posible participación.

Inclusion Criteria:

  • Males or females, age ≥ 18 years.
  • Patients with an active Implantable Cardioverter Defibrillator (ICD).
  • Left Ventricular Ejection Fraction (LVEF) ≤ 40%, measured within the past year (12 months).
  • Able and willing to provide written informed consent before undergoing any study-related procedures.

Exclusion Criteria:

  • Any condition that by the judgement of the physician investigator precludes the subject’s ability to comply with the study requirements.
  • Any known skin allergy or sensitivity to the study garment materials that will be next to the skin.
  • Any breached or compromised skin on the upper torso that would be exacerbated by wearing the study garment.
  • Work with or are frequently around equipment that produces high electromagnetic fields, for example magnetic resonance imaging devices, power supply facilities, or welding equipment.
  • Any planned surgical or medical procedures during the participation period.
  • Any planned air travel during the participation period.
  • Cognitive and/or physical limitations that would prevent the subject from interacting with the device as intended.
  • Pregnancy.
  • Use of mechanical circulatory support, for example Left Ventricular Assist Device (LVAD) or Total Artificial Heart.
  • Implanted Cardiac Resynchronization Therapy Defibrillator (CRT-D).
  • Pacing pulse width > 1ms.
  • Simultaneous plan/prescription for Holter monitor, mobile cardiac outpatient telemetry (MCOT), Event Recorder, or in-hospital telemetry.
  • Use of any electronic medical device that is worn on or near the body requires Sponsor approval, other than continuous positive airway pressure (CPAP), continuous blood glucose monitor, or pulse oximeter oxygen saturation (SpO2) monitor.

Sedes participantes de Mayo Clinic

Los estatus de los estudios cambian con frecuencia. Comunícate con el equipo del estudio para obtener la información más actualizada acerca de la posibilidad de participar.

Sede de Mayo Clinic Estatus

Rochester, Minn.

Investigador principal de Mayo Clinic

Yongmei Cha, M.D.

Cerrado para la inscripción

More information

Publicaciones

Publications are currently not available
.
CLS-20447458

Mayo Clinic Footer